TURNSTONE BIOLOGICS CORP (TSBX) Stock News

NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock - Currency: USD

0.3648 +0 (+0.77%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

TSBX Latest News, Press Relases and Analysis

All

Press Releases

21 days ago - By: Chartmill - Mentions: AVAV OGEN WINT PRPL ...

News Image

Get insights into the top gainers and losers of Friday's after-hours session.

13 days ago - By: Halper Sadeh LLC - Mentions: GMS BGFV

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, TSBX, BGFV on Behalf of Shareholders

21 days ago - By: Brodsky & Smith LLC - Mentions: CARM OCGN GNTY GBCI ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carisma Therapeutics Inc. (Nasdaq - CARM), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC), Turnstone Biologics Corp. (Nasdaq - TSBX)

21 days ago - By: Halper Sadeh LLC

TSBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Turnstone Biologics Corp. Is Fair to Shareholders

21 days ago - By: XOMA Royalty Corporation; Turnstone Biologics Corp. - Mentions: XOMA

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

a month ago - By: Benzinga - Mentions: LIXT ATRA PPBT MODV ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

2 months ago - By: Benzinga - Mentions: EVO OTLK BWAY PDSB ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

2 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights

2 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights

4 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

4 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

5 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

8 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

9 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

9 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

9 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

9 months ago - By: Turnstone Biologics Corp.

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

a year ago - By: InvestorPlace

Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?

a year ago - By: InvestorPlace - Mentions: AISP ALBT ARAY CYTO ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

a year ago - By: InvestorPlace

TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024

a year ago - By: BusinessInsider

News Image

TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024

a year ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

a year ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

a year ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

a year ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

a year ago - By: InvestorPlace

TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024

a year ago - By: BusinessInsider

News Image

TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024

a year ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

a year ago - By: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights